Polar Leasing Adds an Ambient Temperature Pharmaceutical Storage Unit to Its Repertoire
Product is expected to maintain a steady temperature setting between 65°F (18°C) and 80°F (27°C).
Polar Leasing Company, Inc. (PLC), a provider of rental cold storage solutions for the pharma industry, has launched its validated Model A820 Ambient Temperature Walk-In Unit. This unit is designed to accommodate the storage requirement of pharma and life science products that demand a stable ambient (room temperature) environment.
The Model A820 is a ground-resting, electric-powered outdoor model developed to maintain a consistent temperature setting between 65°F (18°C) and 80°F (27°C), independent of external weather conditions. This NSF-approved ambient temperature solution is expected to bring substantial cost savings by eliminating the need for refrigeration and reducing energy consumption, maintenance, and infrastructure expenses.
Bart Tippmann, president of Polar Leasing, notes that while the technology differs from the traditional cold storage designs that customers may come to expect, the company's goals to quality remain the same, explaining that "every Polar Leasing unit, including these state-of-the-art ambient temperature solutions, adheres to the same high-quality standards."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
